TWST
Twist Bioscience CorpNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$3.77B
P/E Ratio
—
EPS
$-1.32
Beta
2.23
52W High
$66.06
52W Low
$23.30
50-Day MA
$53.04
200-Day MA
$39.08
Dividend Yield
—
Profit Margin
-19.90%
Forward P/E
—
PEG Ratio
—
About Twist Bioscience Corp
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $409.48M |
| Gross Profit (TTM) | $213.23M |
| EBITDA | $-109.83M |
| Operating Margin | -34.90% |
| Return on Equity | -18.20% |
| Return on Assets | -12.90% |
| Revenue/Share (TTM) | $6.74 |
| Book Value | $7.32 |
| Price-to-Book | 8.29 |
| Price-to-Sales (TTM) | 9.21 |
| EV/Revenue | 9.03 |
| EV/EBITDA | -35.26 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 19.30% |
| Shares Outstanding | $62.27M |
| Float | $55.41M |
| % Insiders | 1.32% |
| % Institutions | 123.89% |
Historical Volatility
HV 10-Day
79.86%
HV 20-Day
69.80%
HV 30-Day
76.07%
HV 60-Day
72.85%
HV Rank
86.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($64.44 target)
1
Strong Buy7
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026